As of January 2025, BrightPath Biotherapeutics has a market cap of $17.21M. This makes BrightPath Biotherapeutics the world's 28322th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $26.81M | -22.99% |
2023 | $34.82M | -13.00% |
2022 | $40.02M | -10.71% |
2021 | $44.82M | -38.46% |
2020 | $72.83M | -41.85% |
2019 | $125.26M | 49.05% |
2018 | $84.04M | -66.98% |
2017 | $254.52M | -8.36% |
2016 | $277.73M | 162.88% |
2015 | $105.65M | - |